Pediatric Nephrology

, Volume 20, Issue 1, pp 42–45 | Cite as

Urotensin-II levels in children with minimal change nephrotic syndrome

  • Ayse Balat
  • I. Halil Pakir
  • Faysak Gok
  • Ruksen Anarat
  • Saime Sahinoz
Original Article

Abstract

Human urotensin-II (hU-II) is the most potent mammalian vasoconstrictor identified to date. Although it is expressed mainly in the brain and spinal cord, it is also detected in other tissues, such as the kidney. It has been speculated that U-II might be an important physiological mediator of vascular tone and blood pressure in humans. To our knowledge, no studies have investigated the level of U-II in children with minimal change nephrotic syndrome (MCNS). Considering the renal synthesis and vasoactive role of U-II, we aimed to measure the plasma and urinary levels of U-II in children with MCNS, and investigate the correlation with other clinical and laboratory findings. Twenty-six children with clinical MCNS, ranging in age from 2 to 7 years, were compared with 16 healthy age- and sex-matched controls. The median age of the children was 4.73±2.36 years. U-II level was measured by RIA. Plasma U-II concentrations (pg/ml) were decreased during relapse (20.11±14.43 in relapse, 38.94±23.86 in remission, P <0.05), whereas urinary U-II levels (pg/mg urinary creatinine) were significantly higher in relapse than in remission (37.31±28.43 in relapse, 31.09±21.10 in remission, P <0.05). We could not detect any relationship between U-II levels and other clinical and laboratory parameters. Our data indicate that the important changes in plasma and urinary U-II levels during relapse may be the result of heavy proteinuria rather than playing a role in mediating the clinical and laboratory manifestations of MCNS in children.

Keywords

Minimal change nephrotic syndrome Urotensin-II 

References

  1. 1.
    Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95:15803–15808CrossRefPubMedGoogle Scholar
  2. 2.
    Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Douglas SA, et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282–286CrossRefPubMedGoogle Scholar
  3. 3.
    Affolter J, Webb DJ (2001) Urotensin II: a new mediator in cardiopulmonary regulation? Lancet 358:774–775CrossRefPubMedGoogle Scholar
  4. 4.
    Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, İto S, Kimura Y, Sasano H, Murakami O (2001) Role of urotensin II in patients on dialysis. Lancet 358:810–811CrossRefPubMedGoogle Scholar
  5. 5.
    Bottrill FE, Douglas SA, Hiley CR, White R (2000) Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130:1865–1870PubMedGoogle Scholar
  6. 6.
    Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Berry C, Kirk A, Richardson M, Maclean MR (2001) Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol 280:H925–H928Google Scholar
  7. 7.
    Bern HA, Pearson D, Larson BA, Nishioka RS (1985) Neurohormones from fish tails: the caudal neurosecretory system. I. “ Urophysiology” and the caudal neurosecretory system in fishes. Recent Prog Horm Res 41:533–552Google Scholar
  8. 8.
    Nash MA, Edelmann CM Jr, Burnstein J, Barnett HL (1992) Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerular sclerosis. In: Edelmann CM Jr (ed) Pediatric kidney disease, 2nd edn. Little Brown, Boston, pp:1267–1290Google Scholar
  9. 9.
    Kelsall CJ, Balment RJ (1998) Native urotensins influence cortisol secretion and plasma cortisol concentrations in the euryhaline flounder, Platichthys flesus. Gen Comp Endocrinol 112:210–219CrossRefPubMedGoogle Scholar
  10. 10.
    Zhang AY, Chen YF, Zhang DX, Yi FX, Qi J, Andrade-Gordon P, Garavilla L de, Li PL, Zou AP (2003) Urotensin-II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol Renal Physiol 285:F792–F798PubMedGoogle Scholar
  11. 11.
    Sauzeau V, Le ME, Bertoglio J, Scalbert E, Pacaud P, Loirand G (2001) Human urotensin-II induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho kinase. Circ Res 88:1102–1104PubMedGoogle Scholar
  12. 12.
    Watanebe T, Pakala R, Katagiri T, Benedict CR (2001) Synergistic effect of urotensin-II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104:16–18PubMedGoogle Scholar
  13. 13.
    Matsushita M, Shichiri M, Fukai N, Ozawa N, Yoshimoto T, Takasu N, Hirata Y (2003) Urotensin-II is an autocrine/paracrine growth factor for the porcine epithelial cell line, LLCPK1. Endocrinology 144:1825–1831CrossRefPubMedGoogle Scholar
  14. 14.
    Shenouda A, Douglas SA, Ohlstein EH, Giaid A (2002) Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma. J Histochem Cytochem 50:885–889PubMedGoogle Scholar
  15. 15.
    Nothacker HP, Wang Z, McNeill AM, Saito Y, Metren S, O’Dowd B, Duckles SP, Civelli O (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1:383–385CrossRefPubMedGoogle Scholar
  16. 16.
    Gendron G, Simard B, Gobeil F, Sirois P, D’Orleans-Juste P, Regoli D (2004) Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats. Can J Physiol Pharmacol 82:16–21CrossRefPubMedGoogle Scholar
  17. 17.
    Balat A, Cekmen M, Yürekli M, Gülcan H, Kutlu O, Türköz Y, Yologlu S (2000) Adrenomedullin and nitrite levels in children with minimal change nephrotic syndrome. Pediatr Nephrol 15:70–73CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2004

Authors and Affiliations

  • Ayse Balat
    • 1
    • 5
  • I. Halil Pakir
    • 1
  • Faysak Gok
    • 2
  • Ruksen Anarat
    • 3
  • Saime Sahinoz
    • 4
  1. 1.Department of Pediatrics, Medical FacultyGaziantep UniversityGaziantepTurkey
  2. 2.Department of Pediatric NephrologyGulhane Military Medical SchoolAnkaraTurkey
  3. 3.Laboratory of Baskent UniversityAdana HospitalTurkey
  4. 4.Department of Public Health, Medical FacultyGaziantep UniversityGaziantepTurkey
  5. 5.Gaziantep UniversityGaziantepTurkey

Personalised recommendations